Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen Concentrate (Human) for Acute Bleeding in Congenital Fibrinogen Deficiency
NCT00916656Phase 3Withdrawn
- Sponsor
- CSL Limited
- Start
- Oct 2009
- Primary completion
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of Fibrinogen human in congenital fibrinogen deficiency (CFD), sponsored by CSL Limited. Planned start Oct 2009; status: withdrawn.
02
Drugs
Fibrinogen human
03
Conditions
congenital fibrinogen deficiency (CFD)
Beyond the preview
Go deeper on NCT00916656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916656.